These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15877994)

  • 1. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
    Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
    Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials.
    Serebruany VL; Malinin AI; Eisert RM; Sane DC
    Am J Hematol; 2004 Jan; 75(1):40-7. PubMed ID: 14695631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspirin dosage for prevention of cerebral infarct: arguments for low dosage].
    Hennerici MG; Meairs S
    Nervenarzt; 1995 Dec; 66(12):890-4; discussion 885. PubMed ID: 8584072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
    Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis.
    Lanas A; Wu P; Medin J; Mills EJ
    Clin Gastroenterol Hepatol; 2011 Sep; 9(9):762-768.e6. PubMed ID: 21699808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin in patients undergoing percutaneous coronary intervention].
    Güleç S
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():9-13. PubMed ID: 18160361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
    Laine L
    Aliment Pharmacol Ther; 2006 Sep; 24(6):897-908. PubMed ID: 16948802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
    Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
    J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
    Jolly SS; Pogue J; Haladyn K; Peters RJ; Fox KA; Avezum A; Gersh BJ; Rupprecht HJ; Yusuf S; Mehta SR
    Eur Heart J; 2009 Apr; 30(8):900-7. PubMed ID: 18819961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of evidence-based medicine--clinical questions. Is low-dose aspirin a better choice in patients with coronary artery disease and bleeding risks?
    Hsu J; Pack Q; Feldstein DA
    WMJ; 2007 Feb; 106(1):7-8. PubMed ID: 17393749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
    Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.
    Watson PD; Joy PS; Nkonde C; Hessen SE; Karalis DG
    Am J Cardiol; 2009 Oct; 104(8):1052-4. PubMed ID: 19801023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
    Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
    Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin--a drug whose time has gone?
    Tapp L; Shantsila E; Lip GY
    Am J Cardiol; 2010 Feb; 105(4):577-8. PubMed ID: 20152256
    [No Abstract]   [Full Text] [Related]  

  • 18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.